LFST Stock Overview
Through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
LifeStance Health Group, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$6.31 |
52 Week High | US$9.20 |
52 Week Low | US$4.64 |
Beta | 1.2 |
11 Month Change | 12.48% |
3 Month Change | 13.69% |
1 Year Change | -20.13% |
33 Year Change | -61.17% |
5 Year Change | n/a |
Change since IPO | -71.19% |
Recent News & Updates
Here's Why LifeStance Health Group (NASDAQ:LFST) Can Afford Some Debt
Sep 02LifeStance Health Group, Inc. (NASDAQ:LFST) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 11Recent updates
Here's Why LifeStance Health Group (NASDAQ:LFST) Can Afford Some Debt
Sep 02LifeStance Health Group, Inc. (NASDAQ:LFST) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 11LifeStance Health Group, Inc.'s (NASDAQ:LFST) Intrinsic Value Is Potentially 63% Above Its Share Price
Jul 15With LifeStance Health Group, Inc. (NASDAQ:LFST) It Looks Like You'll Get What You Pay For
Jun 07LifeStance: Selloff Opens Buying Opportunity Thanks To Price/Value Dislocation
May 23LifeStance Health Group, Inc. (NASDAQ:LFST) Analysts Are Pretty Bullish On The Stock After Recent Results
May 12Why LifeStance Health Group, Inc. (NASDAQ:LFST) Could Be Worth Watching
May 06Calculating The Intrinsic Value Of LifeStance Health Group, Inc. (NASDAQ:LFST)
Mar 23LifeStance Health Group, Inc. (NASDAQ:LFST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$8.50
Mar 02LifeStance Q4 Earnings Review: Monetizing Mental Health Virtually Is Problematic
Feb 29Does LifeStance Health Group (NASDAQ:LFST) Have A Healthy Balance Sheet?
Feb 28LifeStance Health Group, Inc.'s (NASDAQ:LFST) P/S Still Appears To Be Reasonable
Jan 23What Is LifeStance Health Group, Inc.'s (NASDAQ:LFST) Share Price Doing?
Jul 08Is LifeStance Health Group, Inc. (NASDAQ:LFST) Expensive For A Reason? A Look At Its Intrinsic Value
May 09LifeStance Health appoints new key person
Sep 08Is LifeStance Health Group, Inc. (NASDAQ:LFST) Trading At A 48% Discount?
Sep 05Shareholder Returns
LFST | US Healthcare | US Market | |
---|---|---|---|
7D | -2.3% | 0.7% | 0.5% |
1Y | -20.1% | 17.5% | 22.7% |
Return vs Industry: LFST underperformed the US Healthcare industry which returned 17.5% over the past year.
Return vs Market: LFST underperformed the US Market which returned 22.7% over the past year.
Price Volatility
LFST volatility | |
---|---|
LFST Average Weekly Movement | 6.6% |
Healthcare Industry Average Movement | 6.9% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.0% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: LFST has not had significant price volatility in the past 3 months.
Volatility Over Time: LFST's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2017 | 6,984 | Ken Burdick | lifestance.com |
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder.
LifeStance Health Group, Inc. Fundamentals Summary
LFST fundamental statistics | |
---|---|
Market cap | US$2.41b |
Earnings (TTM) | -US$150.92m |
Revenue (TTM) | US$1.16b |
2.1x
P/S Ratio-16.0x
P/E RatioIs LFST overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LFST income statement (TTM) | |
---|---|
Revenue | US$1.16b |
Cost of Revenue | US$804.21m |
Gross Profit | US$352.06m |
Other Expenses | US$502.97m |
Earnings | -US$150.92m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.39 |
Gross Margin | 30.45% |
Net Profit Margin | -13.05% |
Debt/Equity Ratio | 19.7% |
How did LFST perform over the long term?
See historical performance and comparison